Rethinking funding priorities in mental health research.

Br J Psychiatry 2016 06;208(6):507-9

Roberto Lewis-Fernández, MD, Columbia University Medical Center, and New York State Center of Excellence for Cultural Competence, and Hispanic Treatment Program, at the New York State Psychiatric Institute, New York, USA; Mary Jane Rotheram-Borus, PhD, Department of Psychiatry and Biobehavioral Sciences, Semel Institute, University of California at Los Angeles, Los Angeles, California, USA; Virginia Trotter Betts, MSN, JD, RN, HealthFutures, Inc., Nashville, Tennessee, USA; Lisa Greenman, JD, Attorney At Law, Washington, DC, USA; Susan M. Essock, PhD, Columbia University Medical Center, New York, USA; Javier I. Escobar, MD, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA; Deanna Barch, PhD, Washington University in St Louis, St Louis, Missouri, USA; Michael F. Hogan, PhD, Dartmouth (Geisinger) Medical School, Case Western Reserve Medical School, and New York University Medical School, and Hogan Health Solutions, New York, USA; Patricia A. Areán, PhD, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA; Benjamin G. Druss, MD, MPH, Ralph J. DiClemente, PhD, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA; Thomas H. McGlashan, MD, Yale University School of Medicine, and Connecticut Mental Health Center, New Haven, Connecticut, USA; Dilip V. Jeste, MD, Sam and Rose Stein Institute for Research on Aging, University of California San Diego, San Diego, California, USA; Enola K. Proctor, PhD, Brown School of Social Work, and Center for Mental Health Services Research, Washington University in St Louis, St Louis, Missouri, USA; Pedro Ruiz, MD, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, Florida, USA; A. John Rush, MD, Duke-National University of Singapore, and Duke Medical School, Santa Fe, New Mexico, USA; Glorisa J. Canino, PhD, Behavioral Sciences Research Institute, and Department of Pediatrics, University of Pu

Mental health research funding priorities in high-income countries must balance longer-term investment in identifying neurobiological mechanisms of disease with shorter-term funding of novel prevention and treatment strategies to alleviate the current burden of mental illness. Prioritising one area of science over others risks reduced returns on the entire scientific portfolio.

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.bp.115.179895DOI Listing
June 2016
42 Reads

Publication Analysis

Top Keywords

mental health
8
funding priorities
8
prevention treatment
4
treatment strategies
4
strategies alleviate
4
current burden
4
alleviate current
4
novel prevention
4
neurobiological mechanisms
4
mechanisms disease
4
disease shorter-term
4
shorter-term funding
4
burden mental
4
illness prioritising
4
reduced returns
4
returns entire
4
entire scientific
4
scientific portfolio
4
risks reduced
4
science risks
4

Similar Publications